Systematic Review and Adjusted Indirect Comparison Meta-Analysis of Oral Anticoagulants in Atrial Fibrillation-Reference-Cited by-同舟云学术

Systematic Review and Adjusted Indirect Comparison Meta-Analysis of Oral Anticoagulants in Atrial Fibrillation

Published:2012-09 Issue:5 Volume:5 Page:711-719
ISSN:1941-7713
Container-title:Circulation: Cardiovascular Quality and Outcomes
language:en
Short-container-title:Circ Cardiovasc Qual Outcomes

Author:

Baker William L.¹,Phung Olivia J.¹

Affiliation:

1. From the University of Connecticut Schools of Pharmacy and Medicine, Storrs and Farmington, CT (W.L.B.); and Western University of Health Sciences College of Pharmacy, Pomona, CA (O.J.P.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference42 articles.

1. 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)

2. Antithrombotic Therapy for Atrial Fibrillation

3. Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation

4. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

5. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venous thrombosis during systemic antitumor therapy: risks, prognosis, treatment. A review;Journal of Modern Oncology;2024-03-05

2. ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON);Journal of Diabetes and its Complications;2023-08

3. Apixaban for the Treatment of Cerebral Venous Sinus Thrombosis: A Single-Centre Experience and Systematic Review of the Literature;CNS Drugs;2023-01-17

4. Impact of comparative effectiveness research on Medicare coverage of direct oral anticoagulants;Journal of Comparative Effectiveness Research;2022-10

5. Efficacy and Safety of Direct Oral Anticoagulants (DOACs) Versus Warfarin in Atrial Fibrillation Patients with Prior Stroke: a Systematic Review and Meta-analysis;Cardiovascular Drugs and Therapy;2022-04-25